Feedback PLC Bleepa - the clinical messaging app - at NHS Expo
2019年9月4日 - 3:01PM
RNSニュース (英語)
TIDMFDBK
Feedback PLC
04 September 2019
Feedback plc
Bleepa(TM) - the revolutionary clinical messaging app -
showcased at NHS Expo 2019
Feedback Medical unveils ground-breaking medical imaging
product
Cambridge, 4 September 2019: As previously announced, Feedback
plc (AIM: FDBK, "Feedback" or the "Company"), the specialist
medical imaging technology company, is unveiling its new
revolutionary clinical messaging product, Bleepa(TM) , to over
6,000 conference delegates at NHS Expo in Manchester on 4-5
September 2019.
Dr Tom Oakley, CEO of Feedback, commented:
"We are demonstrating Bleepa(TM) for the first time at Expo with
leaders who are driving digital innovation across the NHS. The role
of digital technology in revolutionising patient care is central to
the NHS Long Term Plan and we believe Bleepa(TM) sits firmly at the
heart of this movement, enabling clinicians to share high quality
medical images and discuss how to give the best possible patient
care securely and quickly via mobile devices."
Bleepa(TM) is an innovative new app based on Feedback's Cadran
technology, which allows medical staff to securely view and discuss
high quality medical grade images on mobile devices. The app will
display images directly from the hospital's Picture Archive
Communication System (PACS). Bleepa(TM) can display any type of
image including X-rays, CTs, MRIs and ultrasound studies allowing
users to easily scroll through image slices and annotate areas of
interest. Questions can be asked alongside annotations and
submitted into the chat where they can be securely reviewed by
colleagues at the swipe of a finger, with instant access to the
original image.
Bleepa(TM) enables faster clinical decisions as doctors will be
able to share, review and discuss images including screen sharing
with multiple staff, both accelerating and improving patient care.
All data and resulting decisions will be stored in hospital records
for later review.
Currently, it is only possible to view medical grade images on
desktop computers and discuss them by telephone. According to BMJ
Innovations, 97% of hospital doctors routinely use WhatsApp to
communicate about patients.(1) This increasing trend for clinicians
to use personal devices to discuss patient care and make clinical
decisions is more convenient and efficient than traditional methods
of clinical communication. However, these images are not of
sufficient quality to make clinical decisions and sharing data in
this way breaches data protection legislation, leaving hospitals
and individual staff open to the risk of litigation.
The Directors believe Bleepa(TM) will be the leading
communication tool on the market and will be a CE marked medical
device.
Bleepa(TM) will be demonstrated and available for pre-order on
stand 29 at NHS England Health and Care Innovation Expo at
Manchester Central, 4 - 5 September 2019. For more information see
www.bleepa.com.
(1) O'Sullivan DM, O'Sullivan E, O'Connor M, et al WhatsApp Doc?
BMJ Innovations 2017;3:238-239.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Instinctif Partners +44 (0)20 7457 2020
Rozi Morris / Phillip Marriage feedbackplc@instinctif.com
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa(TM) , a new secure, encrypted
medical communication app for clinicians accessible through
smartphones, tablets and desktops that facilitates rapid clinical
messaging and review of medical grade imaging for all members of a
clinical team, directly from a hospital Picture Archiving and
Communications System (PACS). For more information on Bleepa(TM),
see www.bleepa.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAUOSBRKKAKRAR
(END) Dow Jones Newswires
September 04, 2019 02:01 ET (06:01 GMT)
Feedback (LSE:FDBK)
過去 株価チャート
から 7 2024 まで 8 2024
Feedback (LSE:FDBK)
過去 株価チャート
から 8 2023 まで 8 2024